These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6865961)

  • 21. Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.
    Dörner I; Brunner H; Schiefer HG; Loos M; Wellensiek HJ
    Infect Immun; 1977 Oct; 18(1):1-7. PubMed ID: 908614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].
    Kanda T; Yoshino H; Ariga T; Yamawaki M; Yu RK
    J Cell Biol; 1994 Jul; 126(1):235-46. PubMed ID: 8027181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation.
    Okada N; Yasuda T; Okada H
    Biochem Biophys Res Commun; 1988 Mar; 151(2):743-8. PubMed ID: 3348808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Avidin attachment to biotinylated amino groups of the erythrocyte membrane eliminates homologous restriction of both classical and alternative pathways of the complement.
    Muzykantov VR; Smirnov MD; Klibanov AL
    FEBS Lett; 1993 Mar; 318(2):108-12. PubMed ID: 8440366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes.
    Ishida T; Yasukawa K; Kojima H; Harashima H; Kiwada H
    Int J Pharm; 2001 Aug; 224(1-2):69-79. PubMed ID: 11472816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.
    Shaio MF; Chen JG
    Infect Immun; 1989 Mar; 57(3):902-6. PubMed ID: 2917791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human IgM antibodies do not activate guinea-pig complement after interaction with soluble antigen.
    van der Zee JS; Beuvery EC; van Ree R; Aalberse RC
    Mol Immunol; 1986 Jun; 23(6):669-73. PubMed ID: 3092033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivity of human monoclonal IgM with nerve glycosphingolipids.
    Hauttecoeur B; Schmitt C; Dubois C; Danon F; Brouet JC
    Clin Exp Immunol; 1990 May; 80(2):181-5. PubMed ID: 1694117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.
    Okada H; Tanaka H; Okada N
    Eur J Immunol; 1983 Apr; 13(4):340-4. PubMed ID: 6221932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
    Chonn A; Cullis PR; Devine DV
    J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR; Richards RL; Guirguis AA
    J Immunol; 1977 Jan; 118(1):342-7. PubMed ID: 830757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
    Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
    Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of antibody-complement mediated cytotoxicity using ATP release induced by a monoclonal antibody against the Burkitt lymphoma associated globotriaosylceramide antigen.
    Wils P; Junqua S; Le Pecq JB
    J Immunol Methods; 1986 Mar; 87(2):217-22. PubMed ID: 2419453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of serum components from different species on destabilizing hydrogenated phosphatidylcholine-based liposomes.
    Liu S; Ishida T; Kiwada H
    Biol Pharm Bull; 1997 Aug; 20(8):874-80. PubMed ID: 9300134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of antibody to galactosyl(alpha 1 leads to 4)galactosyl(beta 1 leads to 4)glucosylceramide.
    Clarke JT; Embil JA
    Biochim Biophys Acta; 1979 Jan; 582(2):283-94. PubMed ID: 760826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.